4th Annual KNI Clinical-Translational Research Symposium
The 2019 Kentucky Neuroscience Institute Clinical-Translational Research Symposium is a daylong event that will provide the opportunity for basic, translational, and clinical neuroscience investigators including trainees, laboratory and program directors throughout the university to discuss their work, share progress, and develop collaborations. The 4th annual event is scheduled for October 4, 2019 in Karpf (PAV A) Auditorium, with the first poster session beginning at 8am.
Presenters can be unde
BLOG: Record-breaking Research Awards Power UK Innovation
University of Kentucky (UK) faculty received $417.1 million in competitive research awards last fiscal year, a record-breaking increase of $83 million over the previous year.
This astounding 25% increase in FY 2019 takes the university to an unprecedented 12% compound annual growth rate over the last three years for grants and contracts to UK.
UK HealthCare is No. 1 in Kentucky; Cancer Care Ranks 33rd Nationally in U.S. News & World Report Ratings
Department of Surgery welcomes three new faculty in August; prepares for others in September
UK HealthCare is No. 1 in Kentucky; Cancer Care Ranks 33rd Nationally, and high performing in four surgeries in U.S. News & World Report Ratings
UK also ranked high performing in Aortic Valve Surgery, Colon Cancer Surgery, Heart Bypass Surgery, and Lung Cancer Surgery
By Kristi Willett
Click here for UKnow story
Request for Applications: UK CCTS Early Career & High Impact Pilot Awards
Preclinical Study of Therapeutic Strategy for Lafora Disease Shows Promise
A team of scientists have designed and tested a novel and promising therapeutic strategy for treating Lafora Disease (LD), a fatal form of childhood epilepsy. This new type of drug, known as an antibody-enzyme fusion, is a first-in-class therapy for LD and an example of precision medicine that has potential for treating other types of aggregate-based neurological diseases.